Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute myeloid leukemia”
Biology and Treatment Strategy of AML in Its Subgroups: Multicenter Randomized Trial by the German Acute Myeloid Leukemia Cooperative Group (AMLCG)
ClinicalTrials.gov study NCT00266136. IPD Sharing: Not stated. Countries: 1. Publications: 12.
Safety and Efficacy of Anti-CD123 CAR-T Therapy in Patients With Refractory/ Relapsed CD123+ Acute Myeloid Leukemia.
ClinicalTrials.gov study NCT04014881. IPD Sharing: Not stated. Countries: 1. Publications: 6.
A Study of DSP-2033 (Alvocidib) in Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03563560. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase I/II Trial: BIBF 1120 Added to Low-dose Cytarabine in Elderly Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01488344. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00002517. IPD Sharing: Not stated. Countries: 3. Publications: 2.
Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00151242. IPD Sharing: Not stated. Countries: 2. Publications: 5.
Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms
ClinicalTrials.gov study NCT04797767. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Quizartinib in Japanese Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02834390. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of the Safety and Pharmacokinetics of RO6839921, An MDM2 Antagonist, in Patients With Advanced Cancers, Including Acute Myeloid Leukemia.
ClinicalTrials.gov study NCT02098967. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Pharmacokinetics Variability of Posaconazole (PCZ) and Its Glucuronide Metabolite During Induction and Consolidation Treatments in Patients With Acute Myeloid Leukemia (AML): a Covariate Analysis With
ClinicalTrials.gov study NCT03796533. IPD Sharing: Not stated. Countries: 1. Publications: 1.
CD155 Expression in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06369662. IPD Sharing: NO. Countries: 1. Publications: 8.
Study of Chemotherapy in Combination With All-trans Retinoic Acid (ATRA) With or Without Gemtuzumab Ozogamicin in Patients With Acute Myeloid Leukemia (AML) and Mutant Nucleophosmin-1 (NPM1) Gene Muta
ClinicalTrials.gov study NCT00893399. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00006122. IPD Sharing: Not stated. Countries: 7. Publications: 2.
Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01174888. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemtuzumab Ozogamicin in Induction and Glasdegib in Postremission Therapy in Patients With AML (Acute Myeloid Leukemia)
ClinicalTrials.gov study NCT04093505. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase 1b Study Evaluating AMG 232 Alone and in Combination With Trametinib in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02016729. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Early Allogeneic Blood Stem Cell Transplantation in High-risk Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00188136. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Risk-Adapted Therapy of Acute Myeloid Leukemia of Adults (18-60 Years) According to the Cytogenetic Result
ClinicalTrials.gov study NCT00146120. IPD Sharing: Not stated. Countries: 2. Publications: 6.
Study of Milademetan in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03671564. IPD Sharing: YES. Countries: 1. Publications: 0.
L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00329498. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.